You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 12, 2025

Drug Price Trends for ASPIRIN EC


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for ASPIRIN EC

Average Pharmacy Cost for ASPIRIN EC

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug NameNDCPrice/Unit ($)UnitDate
ASPIRIN EC 325 MG TABLET 46122-0596-02 0.02237 EACH 2025-03-19
ASPIRIN EC 325 MG TABLET 49483-0331-10 0.02237 EACH 2025-03-19
ASPIRIN EC 325 MG TABLET 70000-0014-01 0.02237 EACH 2025-03-19
ASPIRIN EC 325 MG TABLET 49483-0331-01 0.02237 EACH 2025-03-19
ASPIRIN EC 325 MG TABLET 00536-1232-01 0.02237 EACH 2025-03-19
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 5 of 5 entries

Market Analysis and Price Projections for Aspirin EC

Global Market Overview

The global aspirin market is poised for significant growth in the coming years. According to market projections, the global aspirin market is expected to grow at a CAGR of 3.8% from 2024 to 2034, reaching a valuation of USD 4,236.9 million by 2034[1].

Market Size and Share

As of 2020, the global aspirin market size was estimated at US$2.167 billion, and it is projected to reach US$2.558 billion by 2027, growing at a CAGR of 2.40% during this period[2].

Segmentation by Product and Application

The aspirin market is segmented into prescription and over-the-counter (OTC) products. The OTC segment dominates the market due to the widespread use of aspirin for pain relief, fever reduction, and inflammation. In terms of application, aspirin is primarily used for cardiovascular diseases, pain/fever/inflammation, and other medical conditions[2].

Distribution Channels

Aspirin is distributed through various channels, including hospital and retail pharmacies, as well as online channels. The retail pharmacy segment is the largest due to its convenience and widespread availability[2].

Regional Market Dynamics

North America

In North America, particularly in the United States, aspirin prices saw a significant increase in September 2024, reaching 3,300 USD/MT. This surge was driven by strong demand, fiscal stability, and strategic inventory management by key market players. Supply chain disruptions, such as port congestion and transportation delays, also contributed to the price rise[4].

Europe

European aspirin prices also increased in the third quarter of 2024, influenced by strong market fundamentals and supply chain disruptions. In Germany, aspirin prices surged to 3,190 USD/MT in September 2024, driven by strong demand and supply chain issues linked to global shipping crises. Economic factors such as interest rate adjustments by the European Central Bank and slowing inflation also played a role in driving prices upward[4].

Asia

In the Asian region, aspirin prices varied across different countries. In China, prices experienced significant fluctuations, settling at 2,890 USD/MT in September 2024. India saw a relaxation in aspirin prices due to government interventions, such as the reduction of prices for 41 commonly used medicines, including aspirin[3][4].

Price Trends and Projections

Current Price Trends

Aspirin prices have been on an upward trajectory in recent quarters, driven by strong demand, rising production costs, and supply chain disruptions. In the third quarter of 2024, European and North American markets witnessed significant price hikes due to these factors[3][4].

Future Projections

Market analysts predict that aspirin prices will continue to rise in the upcoming months, driven by sustained demand and persistent supply chain challenges. The market outlook remains positive, with potential for further price increases dependent on these factors[3][4].

Supply Chain and Production Costs

Supply chain disruptions, including logistical crises and raw material cost increases, have significantly impacted aspirin prices. For instance, the rise in salicylic acid costs, a key raw material for aspirin, has contributed to the upward trend in aspirin prices across various regions[3][4].

Consumer and Industrial Demand

Consumer demand for aspirin remains strong, particularly for cardiovascular disease prevention and pain relief. Industrial demand from pharmaceutical and healthcare sectors also drives the market. Seasonal demand patterns, such as increased consumption during flu and cold seasons, further influence price movements[3][4].

Government and Regulatory Influences

Government interventions, such as price controls and regulatory adjustments, can significantly impact aspirin prices. For example, the Indian government's decision to reduce the prices of commonly used medicines, including aspirin, has had a direct impact on the market dynamics in the region[3].

Key Players and Strategic Management

Key market players have employed strategic inventory management to mitigate supply chain disruptions and maintain stable supply levels. This proactive approach has helped in managing price volatility and ensuring a steady supply of aspirin to meet consumer demand[4].

Economic and Geopolitical Factors

Economic factors such as interest rate adjustments, inflation rates, and geopolitical events influence aspirin prices. For instance, the European Central Bank's interest rate adjustments and the region's slowing inflation have contributed to the upward trend in aspirin prices in Europe[4].

Price Data for Consumers

For consumers, the cost of aspirin can vary based on the dosage and form of the medication. For example, a supply of 36 aspirin 81 mg oral tablets can cost around $10, while 100 aspirin 325 mg oral tablets can cost from $10.16 to $10.33, depending on the pharmacy and availability[5].

Key Takeaways

  • Market Growth: The global aspirin market is projected to grow at a CAGR of 3.8% from 2024 to 2034.
  • Price Trends: Aspirin prices have been increasing due to strong demand, supply chain disruptions, and rising production costs.
  • Regional Dynamics: North America, Europe, and Asia have seen significant price hikes driven by local market conditions and global factors.
  • Supply Chain: Logistical crises and raw material cost increases are key factors influencing aspirin prices.
  • Government Influence: Regulatory adjustments and price controls can impact market dynamics.
  • Consumer Demand: Strong demand from both consumer and industrial sectors drives the market.

FAQs

1. What is the projected growth rate of the global aspirin market? The global aspirin market is projected to grow at a CAGR of 3.8% from 2024 to 2034[1].

2. What are the main factors driving the increase in aspirin prices? The main factors include strong demand, supply chain disruptions, rising production costs, and strategic inventory management by key market players[3][4].

3. How do government interventions affect aspirin prices? Government interventions, such as price controls and regulatory adjustments, can significantly reduce or stabilize aspirin prices, as seen in India's decision to reduce prices for commonly used medicines[3].

4. What is the current price range for aspirin in the consumer market? The cost for aspirin can range from $10 for 36 tablets of 81 mg aspirin to $10.16 to $10.33 for 100 tablets of 325 mg aspirin, depending on the pharmacy and availability[5].

5. What role do economic and geopolitical factors play in aspirin price trends? Economic factors such as interest rate adjustments and inflation rates, along with geopolitical events like global shipping crises, can influence aspirin prices by affecting supply chains and demand patterns[4].

Cited Sources

  1. Drug Patent Watch - Pharmaceutical drug prices and trends for ASPIRIN[1].
  2. Knowledge Sourcing - Global Aspirin Market Size & Share: Industry Report, 2022-2027[2].
  3. Procurement Resource - Aspirin Price Trend, Index, News, Chart, Database[3].
  4. OpenPR - Analyzing Global Aspirin Prices Report, Latest Trend, Historical & Forecast Data[4].
  5. Drugs.com - Aspirin Prices, Coupons, Copay Cards & Patient Assistance[5].

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.